← FDA DRUG APPROVALS

FDA ANDA · ANDA074811

HALOPERIDOL DECANOATE

Sponsor: HIKMA

APPLICATION
ANDA074811
TYPE
ANDA
ORIGINAL APPROVAL
1998-01-30
LATEST ACTION
2011-09-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HALOPERIDOL DECANOATEDiscontinued
HALOPERIDOL DECANOATE EQ 50MG BASE/ML · INJECTABLE · INJECTION

Approval history

2011-09-27Labeling · Supplement 17AP
2011-09-27Labeling · Supplement 15AP
2010-01-07Labeling · Supplement 13AP
2008-11-19Labeling · Supplement 12AP
2008-06-18Labeling · Supplement 11AP
2008-02-04Labeling · Supplement 10AP
2001-10-16Labeling · Supplement 1AP
2001-04-03Manufacturing (CMC) · Supplement 2AP
1998-01-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →